New mechanisms of AML1 gene alteration in hematological malignancies - PubMed (original) (raw)
Review
New mechanisms of AML1 gene alteration in hematological malignancies
C Roumier et al. Leukemia. 2003 Jan.
Abstract
The human AML1 gene (also named CBFA2 or RUNX1), located in the 21q22 chromosomal band, encodes for one of the two subunits forming a heterodimeric transcription factor, the human core binding factor (CBF). AML1 protein contains a highly evolutionary conserved domain of 128 amino acids called runt domain, responsible for both heterodimerization with the beta subunit of CBF and for DNA binding. AML1 is normally expressed in all hematopoietic lineages and acts to regulate the expression of various genes specific to hematopoiesis playing a pivotal role in myeloid differentiation. AML1 is one of the genes most frequently deregulated in leukemia through different mechanisms including translocation, mutation and amplification. Translocations lead to the formation of fusion genes encoding for chimerical proteins such as AML1-ETO which induces leukemogenesis. Recently, new mechanisms of AML1 deregulation by point mutations or amplification have been reported. To our knowledge, 51 patients (among 805 studied) with AML1 point mutations have been described. Forty of them have acute myeloid leukemia (AML) most often M0 AML. In this subtype of AML, the frequency of AML1 mutation is significantly higher; 21.5% of patients mutated (34/158). Mutations have also been found with lower frequency in other FAB subtype AML (6 cases), in myeloproliferative disorders (6 cases), in myelodysplastic syndrome (3 cases) and rarely in acute lymphoblastic leukemia (1 case). AML1 gene amplification has been found essentially in childhood ALL (12 cases) and more rarely in myeloid malignancies (4 cases). Here, we reviewed all these cases of AML1 point mutations and amplification and focused on the mechanisms of AML1 deregulation induced by these alterations.
Similar articles
- The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F, Pisegna S, Diverio D. Lo Coco F, et al. Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review. - AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
Taketani T, Taki T, Takita J, Tsuchida M, Hanada R, Hongo T, Kaneko T, Manabe A, Ida K, Hayashi Y. Taketani T, et al. Genes Chromosomes Cancer. 2003 Sep;38(1):1-7. doi: 10.1002/gcc.10246. Genes Chromosomes Cancer. 2003. PMID: 12874780 - High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL, Dastugue N, Macintyre E, Denis C, Bauters F, Kerckaert JP, Cosson A, Fenaux P. Preudhomme C, et al. Blood. 2000 Oct 15;96(8):2862-9. Blood. 2000. PMID: 11023523 - The 8;21 translocation in leukemogenesis.
Peterson LF, Zhang DE. Peterson LF, et al. Oncogene. 2004 May 24;23(24):4255-62. doi: 10.1038/sj.onc.1207727. Oncogene. 2004. PMID: 15156181 Review.
Cited by
- Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia.
He J, Munir F, Catueno S, Connors JS, Gibson A, Robusto L, McCall D, Nunez C, Roth M, Tewari P, Garces S, Cuglievan B, Garcia MB. He J, et al. Cancers (Basel). 2024 Feb 21;16(5):858. doi: 10.3390/cancers16050858. Cancers (Basel). 2024. PMID: 38473221 Free PMC article. Review. - Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.
Branford S, Kim DDH, Apperley JF, Eide CA, Mustjoki S, Ong ST, Nteliopoulos G, Ernst T, Chuah C, Gambacorti-Passerini C, Mauro MJ, Druker BJ, Kim DW, Mahon FX, Cortes J, Radich JP, Hochhaus A, Hughes TP; International CML Foundation Genomics Alliance. Branford S, et al. Leukemia. 2019 Aug;33(8):1835-1850. doi: 10.1038/s41375-019-0512-y. Epub 2019 Jun 17. Leukemia. 2019. PMID: 31209280 Free PMC article. Review. - Thermodynamic investigation of DNA-binding affinity of wild-type and mutant transcription factor RUNX1.
Wu F, Song T, Yao Y, Song Y. Wu F, et al. PLoS One. 2019 May 2;14(5):e0216203. doi: 10.1371/journal.pone.0216203. eCollection 2019. PLoS One. 2019. PMID: 31048839 Free PMC article. - Tetrasomy 8 Associated with a Poor Prognosis in Acute Monoblastic Leukemia: A Case Report.
Farag F, Morcus R, Ramachandran P, Josan K, Wang JC. Farag F, et al. Cureus. 2019 Feb 13;11(2):e4068. doi: 10.7759/cureus.4068. Cureus. 2019. PMID: 31016095 Free PMC article. - Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.
Wang L, Wu XY, Jin RM, Zhang BY, Qiu YN. Wang L, et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Oct;37(5):807-810. doi: 10.1007/s11596-017-1809-6. Epub 2017 Oct 20. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 29058300 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical